**Core Concept**
Piperacillin is a broad-spectrum, extended-spectrum penicillin antibiotic with activity against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa (P. aeruginosa). However, its efficacy can be compromised by the emergence of resistance during monotherapy. When used in combination with beta-lactamase inhibitors like tazobactam, piperacillin's activity against gram-negative bacteria is enhanced, particularly against beta-lactamase-producing strains.

**Why the Correct Answer is Right**
Piperacillin's mechanism of action involves the inhibition of bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall. This leads to the disruption of the cell wall's integrity, ultimately causing bacterial cell lysis and death. The addition of tazobactam, a beta-lactamase inhibitor, prevents the degradation of piperacillin by beta-lactamase enzymes produced by gram-negative bacteria, thereby enhancing the antibiotic's efficacy. This combination is particularly effective against P. aeruginosa, a notorious gram-negative rod known for its resistance to many antibiotics.

**Why Each Wrong Option is Incorrect**

**Option A:** Amoxicillin is a narrow-spectrum penicillin antibiotic with limited activity against gram-negative bacteria. It is not typically used against P. aeruginosa and does not require a beta-lactamase inhibitor to enhance its efficacy.

**Option B:** Aztreonam is a monobactam antibiotic with activity against gram-negative bacteria, including P. aeruginosa. However, it is not typically used in combination with beta-lactamase inhibitors, and its use is not contraindicated in penicillin-allergic patients.

**Option D:** Vancomycin is a glycopeptide antibiotic with activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is not effective against gram-negative bacteria and does not require a beta-lactamase inhibitor to enhance its efficacy.

**Clinical Pearl / High-Yield Fact**
When using piperacillin-tazobactam in combination, it is essential to monitor for signs of beta-lactamase inhibitor toxicity, such as gastrointestinal disturbances and altered mental status. This combination is a valuable option for treating severe infections caused by beta-lactamase-producing gram-negative bacteria, including P. aeruginosa.

**✓ Correct Answer: C. Piperacillin**